Covalon Technologies Ltd. announced that the Company has been granted key antimicrobial patents by the United States Patent and Trademark Office ("USPTO"), the Canadian Intellectual Property Office ("CIPO"), and the European Patent Office ("EPO"). Covalon's Antimicrobial Silicone-based Wound Dressing patent has been granted in the United States by the USPTO, in Canada by the CIPO, and in Europe by the EPO. This antimicrobial patent is integral to the Company's CovaClear platform technology and the Company's IV Clear, MediClear PreOp, and SurgiClear products. The USPTO also granted the Company a patent for a Method for the Reduction of Microbial Skin Flora, which protects the Company's novel product MediClear PreOp. MediClear PreOp is indicated for use as a pre-operative drape that provides continuous antimicrobial activity to reduce the risk of contamination of the skin prior to a surgical procedure.